NCT02773095View on ClinicalTrials.gov

Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative

NACompletedINTERVENTIONAL
Enrollment

966

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Cardiovascular DiseaseDiabetes Type IIBreast CancerAsthma
Interventions
OTHER

Novartis Access

Eight counties will be matched in pairs and randomized within each pair to either receive Novartis Access portfolio low-cost medications or to remain a control county.

All Listed Sponsors
collaborator

Innovations for Poverty Action

OTHER

lead

Boston University

OTHER

NCT02773095 - Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative | Biotech Hunter | Biotech Hunter